Pain Management
Jul 25, 2024
The following is a summary of “Chronic fatigue in the general population: Prevalence, natural course and associations with chronic pain (the HUNT pain study),” published in the June 2024 issue of ...
Jul 25, 2024
WEDNESDAY, July 24, 2024 (HealthDay News) -- Approximately four in 10 patients with osteoarthritis (OA) or rheumatoid arthritis (RA) have anxiety, depression, or fibromyalgia, according to a study pu...
Jul 25, 2024
WEDNESDAY, July 24, 2024 (HealthDay News) -- A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in&n...
Jul 24, 2024
For older nursing home (NH) residents, use of CYP2D6-metabolized opioids concomitantly with CYP2D6-inhibiting antidepressants is associated with worsening pain and increased risk of opioid-related adv...
Jul 24, 2024
Physical activity may be particularly important to manage depression symptoms in people with greater osteoarthritis-related pain, according to a study published online July 18 in PLOS Global Public He...
Jul 23, 2024
Certain categories of environmental toxicants are associated with depressive symptoms, according to a study published in JAMA Network Open. The study authors screened and assessed the associations bet...
Jul 23, 2024
For patients with opioid use disorder receiving methadone maintenance treatment (MMT), eight weeks of acupuncture is superior to sham acupuncture for reducing methadone dose and opioid craving, accord...
Jul 19, 2024
The following is a summary of “Transcutaneous Electrical Nerve Stimulation Integrated into Pants for the Relief of Postoperative Pain in Hip Surgery Patients: A Randomized Trial,” published in the...
Jul 19, 2024
The age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults, according to a study published in the July issue of Arthr...
Jul 19, 2024
THURSDAY, July 18, 2024 (HealthDay News) -- Most reviews of the use of massage therapy for painful adult health conditions report low- or very low-certainty evidence, according to a review published ...
Jul 17, 2024
The following is a summary of “Virtual Reality for Postsurgical Pain Management: An explorative randomized controlled study,” published in the July 2024 issue of Surgery by Lier et al. Virt...
Jul 17, 2024
For patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published...
Jul 13, 2024
The following is a summary of “Impacts of social determinants of health on chronic opioid therapy for chronic non-cancer pain,” published in the June 2024 issue of Pain by Chan, et al. With...
Jul 13, 2024
The following is a summary of “Myofascial pain – A major player in musculoskeletal pain,” published in the April 2024 issue of Rheumatology by Lam et al. Myofascial pain syndrome is a pre...
Jul 12, 2024
The following is a summary of "SVEAT score: Acute chest pain risk stratification," published in the June 2024 issue of Emergency Medicine by Gol, et al. For a study, researchers sought to compa...
Jul 10, 2024
For patients with degenerative lumbar spinal stenosis (DLSS) and predominantly neurogenic claudication pain symptoms, acupuncture may relieve pain-specific disability, according to a study published o...
Jul 08, 2024
The following is a summary of “Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials,” published in the May 2024 issu...
Jul 08, 2024
The following is a summary of “Associations of pain sensitivity and conditioned pain modulation with physical activity: findings from the Multicenter Osteoarthritis Study (MOST),” published in the...
Jul 07, 2024
Distinct phenotypic and urine biological characteristics are seen for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with a history of ulcerative Hunner lesions (UIC) and those wit...
Jul 03, 2024
TUESDAY, July 2, 2024 (HealthDay News) -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are consider...